- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: HER2-HER3 dimer
Total 3286 results
-
Dana-Farber Cancer InstituteGenentech, Inc.RecruitingSalivary Gland Cancer | HER2 Gene MutationUnited States
-
Jules Bordet InstituteRoche Pharma AGActive, not recruitingHER-2 Positive Breast CancerBelgium, Netherlands
-
Tongji HospitalRecruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingEarly-stage Breast Cancer | Breast Cancer Invasive | HER2 Low Breast Carcinoma | Hormone-receptor-positive Breast CancerChina
-
RemeGen Co., Ltd.Recruiting
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerCanada, Korea, Republic of, Taiwan, United States, Italy, United Kingdom, Thailand, Russian Federation, India, Belgium, Australia, Poland, Spain, Japan, Brazil, Czechia, Netherlands
-
Memorial Sloan Kettering Cancer CenterPuma Biotechnology, Inc.Active, not recruitingBreast CancerUnited States
-
Yonsei UniversityCompletedHER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract CancerKorea, Republic of
-
Helsinki University Central HospitalActive, not recruiting
-
Fudan UniversityUnknown
-
First Affiliated Hospital of Harbin Medical UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUnknownPancreatic Cancer | CARChina
-
RemeGen Co., Ltd.Completed
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States, Canada, Finland, France, Italy, Spain, Taiwan, United Kingdom
-
UNICANCERActive, not recruiting
-
Borstkanker Onderzoek GroepRoche Pharma AG; BOOG Study CenterActive, not recruiting
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingUnresectable Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Metastatic Breast Adenocarcinoma | Metastatic HER2-Positive Breast Carcinoma | Recurrent Breast Adenocarcinoma | Recurrent HER2-Positive Breast Carcinoma | Unresectable HER2-Positive Breast CarcinomaUnited States, Canada
-
Nippon Kayaku Co., Ltd.CompletedTriple Negative Breast CancerUnited States
-
SUNHO(China)BioPharmaceutical CO., Ltd.RecruitingAdvanced Solid TumorChina
-
AstraZenecaQuintiles; University of Tubingen - GermanyCompletedBreast CancerUnited States, Bulgaria, Italy, Korea, Republic of, Russian Federation, Spain, Turkey, Canada, Poland, Australia, Hungary, Taiwan, Japan, Germany, United Kingdom
-
Guangdong Academy of Medical SciencesGuangzhou First People's Hospital; Guangzhou General Hospital of Guangzhou... and other collaboratorsUnknownHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastChina
-
Fudan UniversityHoffmann-La RocheUnknown
-
Henan Cancer HospitalRecruitingHER2 Low Breast CarcinomaChina
-
University of NebraskaNational Cancer Institute (NCI)Active, not recruitingHER2 Positive Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7United States
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Illinois at ChicagoNot yet recruitingBreast Cancer | HER2-positive Breast Cancer
-
The Netherlands Cancer InstituteAstraZeneca; Daiichi SankyoRecruiting
-
Henan Cancer HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingHER2-positive Breast CancerChina
-
Institut de cancérologie Strasbourg EuropeNot yet recruitingProtocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C) (PHARE-C)HER2-positive Breast Cancer
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingHER2-negative Breast Cancer
-
Peking UniversityRecruitingHER2-positive Breast CancerChina
-
University of Alabama at BirminghamRecruitingHER2-positive Breast CancerUnited States
-
xuexin heNot yet recruitingHER2-positive Breast Cancer
-
NSABP Foundation IncGenentech, Inc.; Celcuity, LLCRecruitingHER2-negative Breast CancerUnited States
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLC; Breast Cancer Research FoundationActive, not recruitingBreast Cancer | HER2-positive Breast CancerUnited States
-
Seagen Inc.Active, not recruitingHER2 Positive Breast CancerUnited States
-
Fox Chase Cancer CenterGenentech, Inc.Active, not recruitingHER2-positive Breast CancerUnited States
-
Zhejiang Hisun Pharmaceutical Co. Ltd.Completed
-
Fondazione Policlinico Universitario Agostino Gemelli...Active, not recruiting
-
BeiGeneCompletedHER2-negative Breast CancerChina
-
Alteogen, Inc.CompletedHER2-positive Breast CancerKorea, Republic of
-
NSABP Foundation IncEisai Inc.CompletedBreast Cancer | HER2-negative Breast CancerUnited States, Canada
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingHER2-positive Breast CancerChina
-
Biyun Wang, MDCompleted
-
Sichuan Provincial People's HospitalUnknownHER2-negative Breast CancerChina
-
Guangdong Provincial People's HospitalCompletedHER2-Positive Breast CancerChina
-
Sun Yat-sen UniversityCompletedHER2 Positive Breast CancerChina
-
Guangdong Provincial People's HospitalUnknownHER2-Positive Breast CancerChina
-
Anhui Provincial HospitalUnknownHER2 Positive Breast Carcinoma